NIH-funded research NIH-funded research

Dose guide for physical activity to improve arthritis symptoms

Official title: Examination of the Dose Response Relationship Between Physical Activity and Arthritis-Attributable Outcomes

Funded at University of South Carolina at Columbia · NIH-11503934 · Data updated 2026-11-12

A study from the University of South Carolina will look at how different amounts of weekly physical activity affect arthritis symptoms and quality of life in adults with arthritis.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of South Carolina at Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startSeptember 30, 2024
Project endSeptember 29, 2029
Funding year2026
Award (this year)$249,764
NIH project number5U48DP006850-03
Project IDNIH-11503934 on NIH RePORTER

Who could benefit from this research

Could help

Adults with arthritis who have difficulty meeting current physical activity guidelines.

Less likely to help

Adults without arthritis or those who cannot safely participate in MVPA will likely receive little or no benefit.

What this research studies

This project tests whether three different weekly amounts of moderate-to-vigorous physical activity (MVPA) – 45, 90, or 150 minutes – can lead to better physical function, mood, pain, and quality of life at 6 and 12 months. Researchers will use objective activity measurements and track changes in fatigue, pain, depressive symptoms, confidence, and happiness after MVPA sessions. The findings could help doctors tailor simple, feasible activity goals for adults with arthritis who struggle to meet higher activity targets. Participants will engage in monitored activity and complete surveys to capture short- and longer-term effects.

Why it matters

Potential benefit: If successful, results could provide concrete, attainable activity goals that improve arthritis symptoms and quality of life.

How similar studies have gone: Previous work suggests activity can help arthritis symptoms, but the minimal effective dose is not well established; this study targets that gap.

Where this research is happening

  • University of South Carolina at Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Pellegrini, Christine Ann — University of South Carolina at Columbia
  • Study coordinator: Pellegrini, Christine Ann

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.